ClearMed
Back to Today's BriefingsClinical Knowledge Graph · 500 Studies Indexed

Therapeutic & Molecular Ontology

Drug, Gene & Biomarker Index

Navigate peer-reviewed breakthroughs by pharmacological class, genetic target, circulating biomarker, or diagnostic modality. Select any clinical entity to inspect all linked studies.

Everyday Health & Science Hubs

Indexed Entities (24)

Drug / Therapy6 Peer-Reviewed Briefings

Long-Acting Antivirals & PrEP

Capsid inhibitors (lenacapavir), integrase inhibitors, and direct-acting antiviral regimens.

Active Specialties:Infectious DiseasePsychiatry
INFECTIOUS DISEASE · PRECLINICAL

Combination antiviral treatment for a patient with lymphocytic choriomeningitis virus meningoencephalitis associated with bispecific antibody teclistamab therapy for myeloma

Finally, the case provides preliminary evidence supporting combination antiviral therapy in persistent LCMV infection. Molnupiravir was later substituted for favipiravir, and favipiravir dosing was guided by serum and CSF therapeutic drug monitoring.

2/5 Preclinical
Evidence Meter · 2/5

Animal & Preclinical Data

Demonstrated in living animal models before large-scale human safety and dosing trials begin.

1 min readThe Lancet Infectious Diseases
PSYCHIATRY · RANDOMIZED CLINICAL TRIAL

Mobile Units for Integrated Addiction and HIV Prevention Services for People Who Inject Drugs: The HPTN 094 Randomized Clinical Trial

In this randomized clinical trial, mobile delivery of integrated HIV prevention, addiction, and navigation services did not improve primary outcomes beyond peer navigation alone. The significantly lower all-cause death rate at 52 weeks in the treatment group bears replication for delivering integrated PrEP and MOUD services to people who inject drugs.

5/5 Gold Standard
Evidence Meter · 5/5

Gold-Standard Human Evidence

Backed by randomized controlled human trials or a formal meta-analysis pooling multiple clinical studies.

1 min readJAMA Psychiatry
INFECTIOUS DISEASE · REAL-WORLD COHORT

Soluble Indicators of Endothelial Injury and Activation Emerge During Acute HIV Infection and Persist Despite Rapid Antiretroviral Therapy Initiation

endothelial (blood-vessel lining) and hemostatic perturbations emerge during AHI and correlate with HIV-related parameters. Despite suppressive ART, RV254 participants remained about 3.5 times more likely than PWoH to exhibit an endothelial activation biomarker (measurable biological signal) phenotype.

3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readThe Journal of Infectious Diseases
INFECTIOUS DISEASE · CLINICAL PRACTICE

Evaluation of gut microbiota composition in elite controllers and antiretroviral-treated people with HIV after aspirin versus atorvastatin administration

These findings suggest that ECs have gut microbiota resembling virally-suppressed PWH, and aspirin but not atorvastatin may impact gut microbiota diversity in PWH. There was a significant change in beta diversity after aspirin administration, but no difference in microbiota after atorvastatin.

3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readThe Journal of Infectious Diseases
PSYCHIATRY · PRECLINICAL

Prenatal stress reprograms placental signaling and opposes maternal immune activation effects in the fetal brain

These findings identify a conserved placental stress-associated transcriptional program and suggest that stress and MIA affect shared neurodevelopmental pathways in opposing directions. Weighted gene co-expression analysis of fetal brains revealed that prenatal stress and MIA regulate overlapping DNA repair, synaptic, and translational networks in opposite directions, with stress promoting signatures of premature maturation and MIA driving replication stress.

2/5 Preclinical
Evidence Meter · 2/5

Animal & Preclinical Data

Demonstrated in living animal models before large-scale human safety and dosing trials begin.

1 min readMolecular Psychiatry
INFECTIOUS DISEASE · REAL-WORLD COHORT

Plasma Proteome Signature of Immune Inhibition is Associated with Cytomegalovirus in People with HIV-1

These data identify a CMV-associated plasma proteomic signature in treated HIV, characterized by immunoinhibitory/cytotoxic programs, supporting targeting CMV to reduce immune dysregulation and related comorbidities in PWH. Cytomegalovirus (CMV) is highly prevalent and associated with comorbidities in people with HIV-1 (PWH).

3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readThe Journal of Infectious Diseases

Patient & Student Companion

Everyday Lab & Drug Translator

Instant plain-English guides for common blood tests and prescriptions—what normal ranges mean, what high/low values signal, and what to ask your clinician.

Lab Marker3-Month Blood Sugar

HbA1c

Measures the percentage of red blood cell hemoglobin coated with glucose over roughly 90 days.

Normal: below 5.7% · Prediabetes: 5.7%–6.4%

6.5% or higher on two tests diagnoses diabetes; very low values can occur alongside hypoglycemia or hemolytic anemia.

Ask your doctor: “Does my HbA1c match my daily fasting/post-meal glucose trends?”

Lab MarkerArtery Plaque Carrier

LDL Cholesterol

Low-density lipoprotein particles that carry cholesterol into blood vessel walls when circulating in excess.

General optimal: < 100 mg/dL (< 70 or < 55 mg/dL in high-risk hearts)

Sustained elevated LDL accelerates arterial plaque buildup; alongside ApoB, lowering LDL consistently cuts heart attack risk.

Ask your doctor: “Should we also check ApoB or Lipoprotein(a) to gauge my true plaque risk?”

Lab MarkerBone & Immune Hormone

Vitamin D (25-OH)

Blood storage marker reflecting sun-made and dietary vitamin D essential for calcium absorption and bone remodeling.

Sufficient: 20–50 ng/mL (50–125 nmol/L)

Levels under 12–20 ng/mL risk bone softening and secondary hyperparathyroidism; mega-dosing rarely beats correcting true deficiency.

Ask your doctor: “Do my labs actually show deficiency, or is a standard maintenance dose enough?”

Lab MarkerThyroid Thermostat

TSH

Pituitary hormone that signals your thyroid gland to speed up or slow down metabolism.

Typical adult range: ~0.4–4.5 mIU/L

Paradoxically, HIGH TSH usually signals an underactive thyroid (hypothyroidism), while LOW TSH points toward an overactive thyroid.

Ask your doctor: “If my TSH is borderline, should we re-test Free T4 before adjusting anything?”

Lab MarkerKidney Filter Rate

eGFR

Estimated glomerular filtration rate—how many milliliters of blood your kidneys filter every minute.

Healthy adult filter rate: 90+ mL/min/1.73m²

Values persistently below 60 for 3+ months (or elevated urine albumin) mark chronic kidney disease; single dips can simply reflect dehydration or NSAID use.

Ask your doctor: “Should we pair eGFR with a urine albumin-to-creatinine test (uACR)?”

Lab MarkerInflammation Signal

hs-CRP

High-sensitivity C-reactive protein released by the liver in response to infection, tissue stress, or vascular inflammation.

Low cardiovascular risk: < 1.0 mg/L · Elevated: > 3.0 mg/L

Mild chronic elevations flag vascular inflammation; readings above 10 mg/L usually reflect an acute cold, injury, or autoimmune flare.

Ask your doctor: “Was my CRP elevated because of a recent infection, or is it worth repeating when healthy?”

MedicationIncretin Agonists

GLP-1s

Medications (e.g., semaglutide, tirzepatide) mimicking gut satiety hormones to lower blood sugar, slow stomach emptying, and quiet brain appetite signals.

Major RCTs show 12%–22% average weight loss & 20% fewer CV events in high-risk adults

Common early effects include nausea or reflux; maintaining protein intake and resistance exercise helps preserve lean muscle mass.

Ask your doctor: “If I start a GLP-1, how do we protect lean muscle and plan long-term dosing?”

MedicationHMG-CoA Reductase Inhibitors

Statins

First-line daily medications that curb liver cholesterol synthesis and boost LDL plaque particle clearance.

Lowers LDL 30%–55% depending on dose intensity

Decades of randomized trials confirm durable reductions in heart attack, stroke, and cardiovascular death; true severe muscle injury is rare.

Ask your doctor: “What is my 10-year cardiovascular risk score, and what LDL target fits me?”

MedicationFirst-Line Metabolic Therapy

Metformin

Oldest, safest first-line type 2 diabetes drug that reduces excess liver glucose output and improves insulin sensitivity.

Lowers HbA1c by ~1.0%–1.5% without causing low blood sugar alone

Extended-release tablets cut stomach upset dramatically; long-term users should periodically monitor Vitamin B12 and kidney function (eGFR).

Ask your doctor: “Should we check my Vitamin B12 level if I have been on metformin for several years?”

MedicationSerotonin Reuptake Inhibitors

SSRIs

Medications that increase synaptic serotonin availability over 2–6 weeks to treat major depression, OCD, and anxiety disorders.

Full clinical response typically emerges at weeks 4–8

Stopping abruptly can trigger temporary brain-zap withdrawal symptoms; tapering slowly with a clinician avoids discontinuation discomfort.

Ask your doctor: “How long should we evaluate a dose before deciding whether to adjust or combine with CBT?”

SupplementCofactor Mineral

Magnesium

Essential mineral powering 300+ enzymes across nerve firing, muscle relaxation, blood pressure, and ATP energy metabolism.

Adult daily target: 310–420 mg/day from food + supplements

Standard blood serum tests miss mild tissue depletion; glycinate/citrate absorb better than oxide, while high supplemental doses can loosen stools.

Ask your doctor: “Are any of my prescription medicines lowering my magnesium stores?”